Northern
Osteo Physio ChiroHealth education · Melbourne’s north

IV therapy, nutrients and evidence.

Understand the route of administration, the reason for treatment and the difference between a biological theory and a demonstrated benefit.

An infusion is a delivery method

“Intravenous” means administration into a vein. It describes how a substance is delivered, not whether it is needed or whether it will improve a particular symptom. A decision requires a clinical indication, an appropriate formulation and an assessment of benefits and risks.

A useful discussion starts with the problem being investigated. What diagnosis or deficiency is being addressed? What supports that conclusion? Why is this route proposed, and what alternatives are reasonable?

Vitamins and inflammation

Nutrients have normal biological roles, but that fact alone does not demonstrate that giving extra nutrients will reduce a person’s inflammation or pain. Evidence about a diagnosed deficiency is not interchangeable with evidence about people whose nutrient status is adequate.

Ask whether a claim comes from a laboratory experiment, a change in a blood marker or a controlled study measuring outcomes that matter to patients. Those are different levels of evidence. An explanation of a possible mechanism should be labelled as such.

Reading claims about NAD and glutathione

These substances are often discussed using language about cellular processes and antioxidant systems. Such descriptions do not establish a clinical benefit from an infusion. Evidence from a different product, route, population or dose cannot simply be transferred to the treatment being proposed.

This resource does not claim that NAD or glutathione infusions treat inflammation, reverse ageing, improve energy or accelerate injury recovery. Ask for condition-specific human evidence, including its limitations and safety findings, before accepting any proposed benefit.

What NAD, glutathione and nutrients do in the body

NAD is a coenzyme involved in energy metabolism and in reactions used by enzymes involved in cellular maintenance. Its role in normal biology explains scientific interest in NAD-related treatments. It does not mean that an infusion has been shown to improve fatigue, injury recovery or inflammation.

Glutathione is part of the body’s antioxidant system. Oxidative stress and inflammation are related biological processes, but they are not interchangeable diagnoses. A measured change in antioxidant status does not automatically show a reduction in inflammatory disease, pain or disability.

Vitamin C contributes to collagen formation, antioxidant processes and immune function. Magnesium participates in muscle, nerve and many enzyme functions. Correcting an established deficiency has a different clinical purpose from giving extra nutrients to someone who is already adequately nourished. Route, formulation, medical history and the condition being treated all matter.

What the human studies actually measured

A 2019 pilot study of intravenous NAD included 11 men, with eight receiving NAD and three receiving saline. It examined blood and urine metabolites during and after an infusion. This was useful early work on what happens to the substance in the body, not a trial showing that it treats inflammatory pain or reverses ageing.

A 2026 retrospective pilot compared commercially administered NAD and nicotinamide riboside infusions. It reported differences in tolerability, including gastrointestinal symptoms, increased heart rate and chest pressure in the NAD group. It found no significant change in hsCRP, one inflammation marker assessed. Its small, observational design and short follow-up limit what can be concluded about effectiveness and long-term safety.

A six-month randomised trial in 54 adults examined oral glutathione and reported changes in glutathione stores and some laboratory measures. That finding cannot establish the benefit or safety of an intravenous product for a person with inflammatory symptoms. A different route is a different clinical question.

How might these processes relate to inflammation?

Researchers study nutrient status, cellular metabolism and antioxidant systems because they interact with immune and stress responses. This provides a rationale for investigation. To establish a useful treatment, a study still needs to show meaningful benefits in the relevant group of patients, using the proposed formulation and route, with acceptable harms.

For example, a blood marker changing after treatment does not necessarily mean less pain, better movement or reduced disease activity. Those outcomes need to be measured directly. The studies described here do not establish that NAD or glutathione infusions treat musculoskeletal inflammation. Ongoing symptoms should be assessed for their cause rather than attributed to a presumed nutrient shortage.

Hydration: when is a drip relevant?

Drinking fluids is effective for ordinary hydration, and oral rehydration solutions may be useful in suitable circumstances. Severe dehydration needs urgent medical assessment and may require closely monitored fluids through a drip. Choosing that route depends on the clinical situation, not on a general promise of faster wellness.

Delivery into the bloodstream is not the same as guaranteed immediate uptake by every tissue or a proven improvement in how someone feels. Claims about “100% bioavailability” do not answer whether treatment is needed, effective or safe for the person considering it.

Safety and product quality

Needle-based treatment and injectable products require appropriate clinical and product safeguards. Ask who assesses and prescribes, who administers treatment, how product quality and sterility are addressed, and how adverse reactions are managed.

The US FDA has reported serious reactions associated with contaminated material used to compound injectable glutathione. This illustrates why an ingredient’s biological role or use in oral products does not establish the safety of an injectable preparation.

Questions for a qualified clinician

What condition are we treating, and how was it established?
What evidence applies to this exact treatment and route?
What is the expected benefit compared with the alternatives?
What are the relevant risks and contraindications for me?
How will my medicines and medical history be considered?
What monitoring and emergency arrangements are in place?
What will determine whether treatment is continued or stopped?

Make the decision around a clinical need

Discuss unexplained fatigue, pain or other symptoms with a qualified clinician. Ask whether a diagnosis, dietary assessment or other investigation is more appropriate before deciding on treatment. There is no universal infusion schedule for wellness, and a package should not replace an individual clinical decision.

Other recovery technologies

Explore the PEMF, infrared sauna, red light and bioresonance guide for device-specific evidence questions and safety considerations. The supplements guide explains label checks, interactions and duplicate ingredients.

Sources and further reading

General education, not a diagnosis or individual treatment recommendation. Discuss your symptoms and options with a qualified health professional.